Mitchell Ho

Also affiliated with National Cancer Institute, National Cancer Institute, Center for Cancer Research

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.3Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19

Antibody Therapeutics(2020)10.1093/abt/tbaa020

Top 5%

4.3DataRank

Top 5%109 citations

Weihan Liu, Xin Yu, Meng Wu, Janice M. Reichert, Mitchell Ho +1 more

Papers

Driven by 64 papers — median percentile 95. Top paper: “COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19”.

COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19

Antibody Therapeutics(2020)10.1093/abt/tbaa020

Top 5%

4.3DataRank

Top 5%109 citations

Weihan Liu, Xin Yu, Meng Wu, Janice M. Reichert, Mitchell Ho +1 more

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Nature Communications(2024)10.1038/s41467-023-44534-y

N/A

0.712DataRank · unranked

19 citations

Crystal Sao‐Fong Cheung, Zhijian Duan, Li Ou, Maple Wang, Xuejun Chen +32 more

R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling

eLife(2020)10.7554/elife.54469

N/A

0DataRank · unranked

67 citations

Peter van Kerkhof, Ingrid Jordens, Tomas Malinauskas, Ganesh V. Pusapati, Joseph K. McKenna +8 more

Perspectives on the development of neutralizing antibodies against SARS-CoV-2

Antibody Therapeutics(2020)10.1093/abt/tbaa009

N/A

0DataRank · unranked

49 citations

Mitchell Ho

Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic

Antibody Therapeutics(2020)10.1093/abt/tbaa025

N/A

0DataRank · unranked

45 citations

Mitchell Ho, Yaping Sun

Ancient species offers contemporary therapeutics: an update on shark VNAR single domain antibody sequences, phage libraries and potential clinical applications

Antibody Therapeutics(2020)10.1093/abt/tbaa001

N/A

0DataRank · unranked

61 citations

Jessica Hong, Mitchell Ho, Hejiao English

Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update

Biomolecules(2020)10.3390/biom10060934

N/A

0DataRank · unranked

18 citations

Mitchell Ho, Bryan D. Fleming

Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical Applications

Antibody Therapeutics(2020)10.1093/abt/tbaa012

N/A

0DataRank · unranked

7 citations

Run Shen, Rui Hao, Shouye Wang, Mitchell Ho, Yong Zhu

Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage display

Antibody Therapeutics(2020)10.1093/abt/tbaa002

N/A

0DataRank · unranked

1 citations

Ruixue Wang, Jessica Hong, Christopher M. Dower, Brad St. Croix, Mitchell Ho +1 more

ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.31.926972

N/A

0DataRank · unranked

2 citations

Nicholas T. Gutsche, Meghan M. Bell, Rose Berman, Kwamena E. Baidoo, Blake M. Warner +6 more

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001875

N/A

0DataRank · unranked

113 citations

Fang Gao, Zhanhui Gao, Lei Ao, Na Li, Sujuan Ma +9 more

Role of glypican-1 in regulating multiple cellular signaling pathways

American Journal of Physiology-Cell Physiology(2021)10.1152/ajpcell.00290.2021

N/A

0DataRank · unranked

79 citations

Mitchell Ho, Jiajia Pan

T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0115

N/A

0DataRank · unranked

39 citations

Mitchell Ho, Zhijian Duan

CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100297

N/A

0DataRank · unranked

47 citations

Madeline B. Torres, Madeline R. Spetz, Ruixue Wang, Luyi Peng, Meijie Tian +14 more

Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells

Scientific Reports(2021)10.1038/s41598-020-79524-3

N/A

0DataRank · unranked

40 citations

Yifan Zhang, Wangli Zhang, Xin Chen, Tong Xu, Sheng Hu +5 more

Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia

Scientific Reports(2021)10.1038/s41598-021-84695-8

N/A

0DataRank · unranked

22 citations

Geir E. Tjønnfjord, Sandip M. Kanse, Anders Erik Astrup Dahm, Nina Iversen, Christiane Filion Myklebust +7 more

Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3

Pharmacology & Therapeutics(2021)10.1016/j.pharmthera.2021.107892

N/A

0DataRank · unranked

20 citations

Madeline R. Spetz, Dan Li, Mitchell Ho, Nan Li

Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-1025

N/A

0DataRank · unranked

14 citations

Yanmin Chen, Rong Liang, Lanxin Xiang, Jingwen Li, Yuankui Zhu +10 more

Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models

STAR Protocols(2021)10.1016/j.xpro.2021.100942

N/A

0DataRank · unranked

11 citations

Rosa Nguyen, Carol J. Thiele, Mitchell Ho, Nan Li

A novel IgM intranasal intervention against SARS-CoV-2

Antibody Therapeutics(2021)10.1093/abt/tbab019

N/A

0DataRank · unranked

6 citations

Mitchell Ho, Antony Yerabham

Targeting the cancer neoantigens p53 and KRAS with TCR mimic antibodies

Antibody Therapeutics(2021)10.1093/abt/tbab021

N/A

0DataRank · unranked

4 citations

Mitchell Ho, Zhijian Duan

Camel nanobodies broadly neutralize SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.27.465996

N/A

0DataRank · unranked

12 citations

Hyung Joon Kwon, Raúl E. Cachau, Catherine Z. Chen, Kevin John Butay, Zhijian Duan +13 more

An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma

Journal of Clinical Investigation(2022)10.1172/jci155621

N/A

0DataRank · unranked

72 citations

Adam Cheuk, Jun S. Wei, Abdalla Abdelmaksoud, Hsien-Chao Chou, David Milewski +18 more

A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer

Molecular Therapy — Oncolytics(2022)10.1016/j.omto.2022.02.015

N/A

0DataRank · unranked

55 citations

Hejiao English, Jessica Hong, T. Jake Liang, Glenn Merlino, Chi‐Ping Day +2 more

Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2202439119

N/A

0DataRank · unranked

50 citations

Masanori Onda, Nathan Watson, Raffit Hassan, Mitchell Ho, Tapan K. Bera +10 more

Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0073

N/A

0DataRank · unranked

46 citations

Jingli Zhang, Manakamana Khanal, Jessica Hong, Abhilash Venugopalan, Qun Jiang +7 more

Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2201433119

N/A

0DataRank · unranked

37 citations

Hyung Joon Kwon, Raúl E. Cachau, Catherine Z. Chen, Kevin John Butay, Zhijian Duan +13 more

The emergence of AntibodyPlus: the future trend of antibody-based therapeutics

Antibody Therapeutics(2022)10.1093/abt/tbac024

N/A

0DataRank · unranked

14 citations

Shawn Shouye Wang, Zhaohui Sunny Zhou, Mitchell Ho, Yong Zhu

GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0778

N/A

0DataRank · unranked

13 citations

Nan Li, Alex Renn, Hu Zhu, Lu Chen, Min Shen +5 more

Immunotherapy for hepatobiliary cancers: Emerging targets and translational advances

Advances in cancer research(2022)10.1016/bs.acr.2022.01.013

N/A

0DataRank · unranked

12 citations

Shaoli Lin, Jessica Hong, Mitchell Ho, Dan Li

Production and Purification of Shark and Camel Single‐Domain Antibodies from Bacterial and Mammalian Cell Expression Systems

Current Protocols(2022)10.1002/cpz1.459

N/A

0DataRank · unranked

8 citations

Jesse Buffington, Jessica Hong, Mitchell Ho, Zhijian Duan

Generation of Single-Domain Antibody-Based Recombinant Immunotoxins

Methods in molecular biology(2022)10.1007/978-1-0716-2075-5_25

N/A

0DataRank · unranked

6 citations

Mitchell Ho, Bryan D. Fleming

Development of Glypican-2 Targeting Single-Domain Antibody CAR T Cells for Neuroblastoma

Methods in molecular biology(2022)10.1007/978-1-0716-2075-5_23

N/A

0DataRank · unranked

4 citations

Mitchell Ho, Nan Li

Prefusion-Stabilized Lassa Virus Trimer Identifies Neutralizing Nanobodies and Reveals an Apex-Situated Site of Vulnerability

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.21.488985

N/A

0DataRank · unranked

3 citations

Crystal Sao‐Fong Cheung, Zhijian Duan, Yaping Sun, Pengfei Wang, Jeffrey C. Boyington +17 more

Engineered, fully human nanobody-based CAR T cells have enhanced antitumor activity against hepatocellular carcinoma in preclinical models.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e14512

N/A

0DataRank · unranked

1 citations

Dan Li, Nan Li, Mitchell Ho, Aarti Kolluri

Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours

Nature Communications(2023)10.1038/s41467-023-41631-w

N/A

0DataRank · unranked

72 citations

Ruixue Wang, T.W. Liang, Hua Ren, Chaelee Park, Chin‐Hsien Tai +8 more

Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET

Journal of Nuclear Medicine(2023)10.2967/jnumed.122.265171

N/A

0DataRank · unranked

60 citations

Anna King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski +10 more

The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer

Nature Communications(2023)10.1038/s41467-023-37616-4

N/A

0DataRank · unranked

58 citations

Alex Quan, Dan Li, Jiajia Pan, Hua Ren, Gerard D. Hoeltzel +9 more

Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling

Nature Biomedical Engineering(2023)10.1038/s41551-023-01143-w

N/A

0DataRank · unranked

45 citations

Shannon Lange, Besian I. Sejdiu, Jorge Ibañez-Vega, Hao Shi, Xiang Sun +22 more

Cooperative Armoring of CAR and TCR T Cells by T Cell–Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1872

N/A

0DataRank · unranked

40 citations

Ekaterina Doubrovina, Charlotte M. Mousset, Benjamin Y. Jin, Reona Okada, Xiyuan Zhang +13 more

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005881

N/A

0DataRank · unranked

32 citations

Yingying Cao, Reona Okada, Jeyshka M. Reyes‐González, Hannah G Stack, Haiying Qin +8 more

Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC

Hepatology Communications(2023)10.1097/hc9.0000000000000022

N/A

0DataRank · unranked

17 citations

Dan Li, Nan Li, Zhijian Duan, Lewis R. Roberts, Mitchell Ho +1 more

Identification of nurse shark V NAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV ‐2

The FASEB Journal(2023)10.1096/fj.202202099rr

N/A

0DataRank · unranked

16 citations

Zhijian Duan, Hyung Joon Kwon, Jessica Hong, Dan Li, Mingqian Feng +3 more

Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma

Immunology(2023)10.1111/imm.13624

N/A

0DataRank · unranked

21 citations

Siyuan Liu, Dickson Adah, Qingyang Sun, Zhaoduan Liang, Mitchell Ho +2 more

Humanization of the Shark VNAR Single Domain Antibody Using CDR Grafting

Current Protocols(2023)10.1002/cpz1.630

N/A

0DataRank · unranked

10 citations

Yaping Sun, Jessica Hong, Mitchell Ho, Yifan Zhang

A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps624

N/A

0DataRank · unranked

18 citations

M. Cecilia Monge B., Donna Mabry‐Hrones, Kelley Coffman, Stephanie N. Hicks, Bernadette Redd +5 more

Cancer therapy with antibodies

Nature reviews. Cancer(2024)10.1038/s41568-024-00690-x

N/A

0DataRank · unranked

221 citations

Maximilian F. Konig, Drew M. Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Katharine M. Wright +5 more

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008989

N/A

0DataRank · unranked

30 citations

T. Jake Liang, Laura Hutchins, Alexandra A. Wolfarth, Sara Ferrando-Martinez, Byung Ha Lee +2 more

CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200892

N/A

0DataRank · unranked

12 citations

Dan Li, Nan Li, Shaoli Lin, Hua Ren, Jessica Hong +3 more

Sortase-Mediated Site-Specific Conjugation to Prepare Fluorine-18-Labeled Nanobodies

Bioconjugate Chemistry(2024)10.1021/acs.bioconjchem.4c00264

N/A

0DataRank · unranked

11 citations

Jianfeng Shi, Eric Lindberg, Stanley Fayn, Woong Hee Lee, Mitchell Ho +5 more

Development of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma

American Journal Of Pathology(2024)10.1016/j.ajpath.2024.10.021

N/A

0DataRank · unranked

8 citations

Lalitya Andaloori, Matthew Crowe, Shaoli Lin, Jessica Hong, Neeha Zaidi +2 more

Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice

Scientific Reports(2024)10.1038/s41598-024-80636-3

N/A

0DataRank · unranked

3 citations

Khadija Rebbani, Zhijian Duan, Eugene Valkov, Shawn Bryant, Mitchell Ho +3 more

A proteomic atlas of glypican‐3 interacting partners: Identification of alpha‐fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancer

Proteoglycan Research(2024)10.1002/pgr2.70004

N/A

0DataRank · unranked

0 citations

Shaoli Lin, Zhen Xiao, Mitchell Ho, Yifan Zhang

GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-0975

N/A

0DataRank · unranked

9 citations

Jeyshka M. Reyes‐González, Constanza Rodríguez, Taisuke Kondo, Jangsuk Oh, Ming Sun +10 more

CAR NK cell therapy for solid tumors: potential and challenges

Antibody Therapeutics(2025)10.1093/abt/tbaf019

N/A

0DataRank · unranked

7 citations

Mitchell Ho, Yanlin Yu

Generation of Site‐Specifically Labeled Affinity Reagents via Use of a Self‐Labeling Single Domain Antibody

Advanced Science(2025)10.1002/advs.202417160

N/A

0DataRank · unranked

5 citations

Swarnali Roy, Chino C. Cabalteja, Woong Hee Lee, Hima Makala, Kwamena E. Baidoo +8 more

Structural Features of Glypicans and Their Impact on Wnt Signaling in Cancer

Proteoglycan Research(2025)10.1002/pgr2.70029

N/A

0DataRank · unranked

5 citations

Mitchell Ho, Hsi‐En Tsao

Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2587

N/A

0DataRank · unranked

2 citations

Woong Hee Lee, Falguni Basuli, Jianfeng Shi, Hima Makala, Joon‐Yong Chung +13 more

GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201067

N/A

0DataRank · unranked

1 citations

Mia Fanuzzi, Constanza Rodríguez, Jangsuk Oh, Adhithi Sreenivasan, Hannah G Stack +13 more

RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy

Antibody Therapeutics(2025)10.1093/abt/tbaf022

N/A

0DataRank · unranked

2 citations

Xiufen Liu, Wenlong Liu, Jingyu Zhan, Carolyn Maslanka, Di Xia +3 more

Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102378

N/A

0DataRank · unranked

1 citations

Mingyu Huo, Dan Li, Laura Hutchins, Constanza Rodríguez, Jangsuk Oh +15 more

Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice

Gastroenterology(2020)10.1053/j.gastro.2020.02.011

N/A

0DataRank · unranked

163 citations

Nan Li, Yifan Zhang, Haiying Fu, Mingqian Feng, Dina Schneider +22 more

Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.21.689799

N/A

0DataRank · unranked

0 citations

Joon‐Yong Chung, Woong Hee Lee, Divya Nambiar, Julia Sheehan‐Klenk, Hima Makala +12 more

The Role of Glypicans in Cancer Progression and Therapy

Journal of Histochemistry & Cytochemistry(2020)10.1369/0022155420933709

N/A

0DataRank · unranked

88 citations

Madeline R. Spetz, Mitchell Ho, Nan Li

Mitchell Ho

Indexed papers

Top data-sharing exemplar

Papers